Dr. Orna Izakson ND, RH(AHG)More on #covid and #clots. I think this is the heart of most #postCOVID issues, along with #immuneimpairment and #viralreservoir.
Antibody-Activated Endothelial Cells Increase the Risk of Blood Clots with Covid-19
Antiphospholipid antibodies activity may help explain hypercoagulation associated with late stages of Covid-19 and long-haul disease. Blood samples from nearly 250 individuals hospitalized for Covid-19 found that these “rouge” antibodies activate endothelial cells, risking widespread blood clots.